HOOK - HOOKIPA Pharma Inc.
NASDAQ
->
Healthcare
->
Biotechnology
New York,
United States
Type: Equity
HOOK price evolution
HOOK
| (in millions $) | 30 Oct 2024 | 30 Jun 2024 | 31 Mar 2024 | 31 Dec 2023 |
|---|---|---|---|---|
| Current assets | ||||
| Cash | $77.15 | $92.75 | $117.1 | |
| Short term investments | ||||
| Net receivables | $24.99 | $22.56 | $30.77 | $19.27 |
| Inventory | ||||
| Total current assets | $93.16 | $107.35 | $132.71 | $147.12 |
| Long term investments | $0.2 | $0.2 | $0.42 | |
| Property, plant & equipment | $9.72 | $12.02 | $12.3 | $13.21 |
| Goodwill & intangible assets | ||||
| Total noncurrent assets | $17.7 | $13.16 | $14.22 | |
| Total investments | $0.2 | $0.2 | $0.42 | |
| Total assets | $109.73 | $125.05 | $145.87 | $161.34 |
| Current liabilities | ||||
| Accounts payable | $8.96 | $11.31 | $11.2 | $12.5 |
| Deferred revenue | $6.03 | $7.27 | $34.3 | |
| Short long term debt | $1.51 | $2.73 | $2.76 | |
| Total current liabilities | $28.57 | $27.83 | $29.51 | $41.99 |
| Long term debt | $3.39 | $3.35 | $3.8 | |
| Total noncurrent liabilities | $11.15 | $11.84 | $29.49 | |
| Total debt | $4.9 | $6.08 | $6.56 | |
| Total liabilities | $37.93 | $38.98 | $41.35 | $71.48 |
| Shareholders' equity | ||||
| Retained earnings | -$387.81 | -$373.97 | -$354.88 | -$369.26 |
| Other shareholder equity | -$8.58 | -$7.22 | -$7.4 | -$7.93 |
| Total shareholder equity | $86.06 | $104.52 | $89.86 | |
| (in millions $) | 31 Dec 2023 | 31 Jan 2023 | 31 Dec 2021 | 31 Dec 2020 |
|---|---|---|---|---|
| Current assets | ||||
| Cash | $117.1 | $113.03 | $66.49 | $142.74 |
| Short term investments | ||||
| Net receivables | $19.27 | $22.01 | $21.17 | $20.66 |
| Inventory | ||||
| Total current assets | $147.12 | $147.2 | $102.14 | $171.5 |
| Long term investments | $0.42 | $0.42 | $0.42 | $0.43 |
| Property, plant & equipment | $13.21 | $21.98 | $22.11 | $13.97 |
| Goodwill & intangible assets | ||||
| Total noncurrent assets | $14.22 | $23.26 | $23.91 | $16.31 |
| Total investments | $0.42 | $0.42 | $0.42 | $0.43 |
| Total assets | $161.34 | $170.45 | $126.05 | $187.82 |
| Current liabilities | ||||
| Accounts payable | $12.5 | $5.49 | $8.76 | $8.01 |
| Deferred revenue | $34.3 | $41.35 | $5.56 | $4.53 |
| Short long term debt | $2.76 | $3.28 | $4.47 | $2 |
| Total current liabilities | $41.99 | $35.63 | $27.65 | $21.14 |
| Long term debt | $3.8 | $0.91 | $6.13 | $8.36 |
| Total noncurrent liabilities | $29.49 | $32.3 | $8.8 | $10.55 |
| Total debt | $6.56 | $6.5 | $10.6 | $10.35 |
| Total liabilities | $71.48 | $67.94 | $36.45 | $31.69 |
| Shareholders' equity | ||||
| Retained earnings | -$369.26 | -$287.68 | -$222.77 | -$147.1 |
| Other shareholder equity | -$7.93 | -$7.16 | -$4.78 | -$6.07 |
| Total shareholder equity | $89.86 | $102.52 | $89.59 | $156.12 |
| (in millions $) | 30 Oct 2024 | 30 Jun 2024 | 31 Mar 2024 | 31 Dec 2023 |
|---|---|---|---|---|
| Revenue | ||||
| Total revenue | $4.7 | $1.29 | $36.6 | $7.41 |
| Cost of revenue | ||||
| Gross Profit | $1.29 | $36.6 | $7.41 | |
| Operating activities | ||||
| Research & development | $19.75 | $20.17 | $21.16 | |
| Selling, general & administrative | $3.94 | $4.06 | $4.37 | |
| Total operating expenses | $22.3 | $23.75 | $25.49 | $38.3 |
| Operating income | -$22.46 | $11.11 | -$30.89 | |
| Income from continuing operations | ||||
| EBIT | -$19.09 | $14.38 | -$24.61 | |
| Income tax expense | $0.16 | |||
| Interest expense | $0.81 | $0 | $0.05 | |
| Net income | ||||
| Net income | -$13.84 | -$19.09 | $14.38 | -$24.82 |
| Income (for common shares) | -$19.09 | $14.38 | -$24.82 | |
| (in millions $) | 31 Dec 2023 | 31 Dec 2022 | 31 Dec 2021 | 31 Dec 2020 |
|---|---|---|---|---|
| Revenue | ||||
| Total revenue | $20.13 | $14.25 | $18.45 | $19.58 |
| Cost of revenue | ||||
| Gross Profit | $20.13 | $14.25 | $18.45 | $19.58 |
| Operating activities | ||||
| Research & development | $86.42 | $68.64 | $82.85 | $54.79 |
| Selling, general & administrative | $18.63 | $18.76 | $17.27 | $18.08 |
| Total operating expenses | $117.82 | $87.4 | $100.12 | $72.87 |
| Operating income | -$97.69 | -$73.16 | -$81.67 | -$53.28 |
| Income from continuing operations | ||||
| EBIT | -$80.89 | -$64 | -$74.77 | -$43.3 |
| Income tax expense | $0.37 | $0.23 | $0 | |
| Interest expense | $0.32 | $0.69 | $0.9 | $0.79 |
| Net income | ||||
| Net income | -$81.58 | -$64.92 | -$75.67 | -$44.08 |
| Income (for common shares) | -$81.58 | -$64.92 | -$75.67 | -$44.08 |
| (in millions $) | 30 Oct 2024 | 30 Jun 2024 | 31 Mar 2024 | 31 Dec 2023 |
|---|---|---|---|---|
| Net income | -$19.09 | $14.38 | -$24.82 | |
| Operating activities | ||||
| Depreciation | $0.71 | $0.64 | $1.28 | |
| Business acquisitions & disposals | ||||
| Stock-based compensation | $0.46 | -$0.25 | $0.42 | |
| Total cash flows from operations | -$14.38 | -$24.16 | -$11.22 | |
| Investing activities | ||||
| Capital expenditures | -$0.04 | -$0.12 | -$0.42 | |
| Investments | ||||
| Total cash flows from investing | -$0.19 | -$0.04 | -$0.12 | -$0.42 |
| Financing activities | ||||
| Dividends paid | ||||
| Sale and purchase of stock | $21.25 | |||
| Net borrowings | -$1.14 | |||
| Total cash flows from financing | -$1.28 | -$1.14 | -$0.14 | $21.25 |
| Effect of exchange rate | -$0.06 | -$0.04 | -$0.16 | -$0.18 |
| Change in cash and equivalents | -$57.56 | -$15.56 | -$24.41 | $9.6 |
| (in millions $) | 31 Dec 2023 | 31 Dec 2022 | 31 Dec 2021 | 31 Dec 2020 |
|---|---|---|---|---|
| Net income | -$81.58 | -$64.92 | -$75.67 | -$44.08 |
| Operating activities | ||||
| Depreciation | $3.55 | $3.6 | $4.64 | $4.15 |
| Business acquisitions & disposals | ||||
| Stock-based compensation | $2.35 | $5.04 | $7.64 | $8.66 |
| Total cash flows from operations | -$57.52 | -$20 | -$66.02 | -$39.34 |
| Investing activities | ||||
| Capital expenditures | -$4.16 | -$5.02 | -$12.58 | -$2.37 |
| Investments | ||||
| Total cash flows from investing | -$4.16 | -$5.02 | -$12.58 | -$2.37 |
| Financing activities | ||||
| Dividends paid | ||||
| Sale and purchase of stock | $49.04 | $45.69 | $0.2 | $42.64 |
| Net borrowings | -$1.75 | -$2.85 | -$0.44 | -$1.42 |
| Total cash flows from financing | $65.67 | $72.27 | -$0.23 | $73.42 |
| Effect of exchange rate | $0.09 | -$0.72 | $2.57 | -$2.11 |
| Change in cash and equivalents | $3.99 | $47.26 | -$78.83 | $31.71 |
News
Fundamentals
| Market cap | $9.07M |
|---|---|
| Enterprise value | N/A |
| Shares outstanding | 12.05M |
| Revenue | $50.00M |
|---|---|
| EBITDA | N/A |
| EBIT | N/A |
| Net Income | -$43.37M |
| Revenue Q/Q | -31.51% |
| Revenue Y/Y | 143.30% |
| P/E ratio | -0.21 |
|---|---|
| EV/Sales | N/A |
| EV/EBITDA | N/A |
| EV/EBIT | N/A |
| P/S ratio | 0.18 |
| P/B ratio | N/A |
| Book/Share | N/A |
| Cash/Share | N/A |
| EPS | -$3.60 |
|---|---|
| ROA | -32.01% |
| ROE | N/A |
| Debt/Equity | 0.80 |
|---|---|
| Net debt/EBITDA | N/A |
| Current ratio | 3.26 |
| Quick ratio | N/A |